Close
Nordic 9Nordic 9

North East Health Care (investor - Others)

Switzerland north-easthealthcare.ch
See something wrong or missing? Let us know
Offices:Lucerne

North-East Healthcare Investment is a Swiss-based company serving as the investment vehicle of North-East Family Office for direct investments in healthcare related companies.

Average round investment:22.6M USD
Average number per year:1.0
Distribution: 2020 (1)
Portfolio companies: Denmark Reapplix
Mostly invests in: Denmark Denmark (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to North East Health Care

Name Criteria
France Lauxera Capital Partners
60%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
60%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands LSP (Life Sciences Partners)
57%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Denmark Lundbeckfond Ventures
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United Kingdom Agronomics Limited
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden AP4 - Fjärde AP-fonden
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Bengt Julander
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Biocodex
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Columbus Venture Partners
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top